Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
EDITORIAL
Monoclonal antibody treatment for multiple sclerosis and neuromyelitis optica spectrum disorder: An update
- Pages: 131-132
- First Published: 30 August 2022
FOCUSED REVIEW SERIES ON MONOCLONAL ANTIBODY DRUGS: UP TO DATE IN MULTIPLE SCLEROSIS AND NEUROMYELITIS OPTICA SPECTRUM DISORDER
INVITED REVIEWS
Monoclonal antibody drugs for the treatment of multiple sclerosis and neuromyelitis optica spectrum disorder
- Pages: 133-142
- First Published: 25 July 2022
Infectious issues of therapeutic monoclonal antibodies in multiple sclerosis and neuromyelitis optica spectrum disorders
- Pages: 143-155
- First Published: 14 July 2022
Monoclonal antibody treatment during pregnancy and lactation in women with multiple sclerosis or neuromyelitis optica spectrum disorder
- Pages: 156-165
- First Published: 22 July 2022
MS/NMO AND ALLIED DISORDER
ORIGINAL ARTICLE
Radiological characteristics of neuromyelitis optica spectrum disorder in Egypt
- Pages: 172-181
- First Published: 10 February 2022

Magnetic resonance imaging (MRI) plays an important role in the diagnosis of NMOSD based on the 2015 consensus criteria and its differentiation from other mimickers. High frequency of abnormal Spine and Brain MRI findings was found in Egyptian population. Even though no specific patterns were typical for AQP4-seropositive patients, certain findings may suggest NMOSD diagnosis and warrant AQP4-IgGs testing.
GBS/CIDP AND ALLIED DISORDERS
ORIGINAL ARTICLE
Demyelinating neuropathy requires differential diagnosis with vasculitic neuropathy in rheumatoid arthritis: Significance of sural nerve electrophysiology findings
- Pages: 182-189
- First Published: 18 February 2022